For me, the most heartening part of the announcement is FLC's ability to secure a client in the notoriously difficult-to-enter pharmaceutical sector. Demonstrates FLC's technical capabilities to be accepted. To boot, the client is Brazil's largest national pharma group, not an easy feat to say the very least. If FLC can project manage to successful execution, FLC would be boast its credentials to other pharma players around the globe.
